Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff of 10% or more in the S&P 500.

Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst ...

Fintel reports that on August 7, 2025, Stifel upgraded their outlook for ESAB (NYSE:ESAB) from Hold to Buy. Analyst Price ...